Published by Frank Prenesti on 22nd September 2025
(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.
URL: http://www.digitallook.com/dl/news/story/35368226/...